No phaseActive, not recruitingAge-related condition
Individualized Targeting and Neuromodulation of Late-Life Depression (TMS-LLD)
- Sponsor
- University of New Mexico (Academic or other)
- Enrolment
- 24 planned
- Conditions
- Major Depressive Disorder
- Interventions
- rTMS
- Ages
- adults, older adults
- Registry
- NCT04543773
Full record on ClinicalTrials.gov
From the registry
An open-label, single-arm, clinical research study about how to make transcranial magnetic stimulation (TMS), an FDA-approved treatment, more effective for patients with late-life depression using fMRI.
Primary outcomes
- Anterior Cingulate Cortex (ACC) Connectivity
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered